Long-term remission with ustekinumab in a patient with PAPA syndrome suggests the importance of IL-12/IL-23 cytokines in PSTPIP1-associated inflammatory diseases
Paediatrics
Long-term remission with ustekinumab in a patient with PAPA syndrome suggests the importance of IL-12/IL-23 cytokines in PSTPIP1-associated inflammatory diseases
Paediatrics

Long-term remission with ustekinumab in a patient with PAPA syndrome suggests the importance of IL-12/IL-23 cytokines in PSTPIP1-associated inflammatory diseases

Arthritis Rheumatol. 2025 Sep 22. doi: 10.1002/art.43399. Online ahead of print.

NO ABSTRACT

PMID:40977493 | DOI:10.1002/art.43399